Abstract
Rejection is the major barrier to successful transplantation and usually results from the integration of multiple mechanisms. Activation of elements of the innate immune system, triggered as a consequence of tissue injury sustained during cell isolation or organ retrieval as well as ischemia–reperfusion, will initiate and amplify the adaptive response. For cell mediated rejection, T cells require multiple signals for activation, the minimum being two signals; antigen recognition and costimulation. The majority of B cells require help from T cells to initiate alloantibody production. Antibodies reactive to donor HLA molecules, minor histocompatibility antigens, endothelial cells, red blood cells, or autoantigens can trigger or contribute to rejection early as well as late after transplantation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pallet N, Fougeray S, Beaune P, Legendre C, Thervet E, Anglicheau D (2009) Endoplasmic reticulum stress: an unrecognized actor in solid organ transplantation. Transplantation 88(5):605–613. doi:10.1097/TP.0b013e3181b22cec
Mühlberger I, Perco P, Fechete R, Mayer B, Oberbauer R (2009) Biomarkers in renal transplantation ischemia reperfusion injury. Transplantation 88(3S):S14–S19. doi:10.1097/TP.0b013e3181af65b5
Famulski KS, Broderick G, Einecke G, Hay K, Cruz J, Sis B et al (2007) Transcriptome analysis reveals heterogeneity in the injury response of kidney transplants. Am J Transplant 7(11):2483–2495
Kim IK, Bedi DS, Denecke C, Ge X, Tullius SG (2008) Impact of innate and adaptive immunity on rejection and tolerance. Transplantation 86(7):889–894. doi:10.1097/TP.0b013e318186ac4a
Wilhelm MJ, Pratschke J, Beato F, Taal M, Kusaka M, Hancock WW et al (2000) Activation of the heart by donor brain death accelerates acute rejection after transplantation. Circulation 102(19):2426–2433
Ogura Y, Sutterwala FS, Flavell RA (2006) The inflammasome: first line of the immune response to cell stress. Cell 126(4):659–662
Carvalho-Gaspar M, Billing JS, Spriewald BM, Wood KJ (2005) Chemokine gene expression during allograft rejection: comparison of two quantitative PCR techniques. J Immunol Methods 301(1–2):41–52
Larsen C, Morris P, Austyn J (1990) Migration of dendritic leukocytes form cardiac allografts into host spleens: a novel pathway for initiation of rejection. J Exp Med 171:307–314
van Kooten C, Lombardi G, Gelderman KA, Sagoo P, Buckland M, Lechler R et al (2011) Dendritic cells as a tool to induce transplantation tolerance: obstacles and opportunities. Transplantation 91(1):2–7. doi:10.1097/TP.0b013e31820263b3
Dierselhuis M, Goulmy E (2009) The relevance of minor histocompatibility antigens in solid organ transplantation. Curr Opin Organ Transplant 14(4):419–425. doi:10.1097/MOT.0b013e32832d399c
Afzali B, Lombardi G, Lechler RI (2008) Pathways of major histocompatibility complex allorecognition. Curr Opin Organ Transplant 13(4):438–444. doi:10.1097/MOT.0b013e328309ee31
Kinnear G, Jones ND, Wood KJ (2013) Costimulation blockade: current perspectives and implications for therapy. Transplantation 95(4):527–535
Greenwald RJ, Freeman GJ, Sharpe AH (2005) The B7 family revisited. Annu Rev Immunol 23(1):515–548
Li XC, Rothstein DM, Sayegh MH (2009) Costimulatory pathways in transplantation: challenges and new developments. Immunol Rev 229(1):271–293
Walunas T, Lenschow D, Bakker C, Linsley P, Freeman G, Green J et al (1994) CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405–413
Burrell BE, Bishop DK (2010) Th17 cells and transplant acceptance. Transplantation 90(9):945–948. doi:10.1097/TP.0b013e3181f5c3de
Barbara J, Turvery S, Kingsley C, Spriewald B, Hara M, Witzke O et al (2000) Islet allograft rejection can be mediated by CD4+, alloantigen experienced direct pathway T cells or TH1 and TH2 cytokine phenotype. Transplantation 70:1641–1649
Chen Y, Wood KJ (2007) Interleukin-23 and TH17 cells in transplantation immunity: does 23 + 17 equal rejection? Transplantation 84:1071–1074
Heidt S, San Segundo D, Chadha R, Wood KJ (2010) The impact of Th17 cells on transplant rejection and the induction of tolerance. Curr Opin Organ Transplant 15(4):456–461. doi:10.1097/MOT.0b013e32833b9bfb
Chadha R, Heidt S, Wood KJ (2011) Th17: contributors to allograft rejection and a barrier to the induction of transplantation tolerance? Transplantation 91(9):939–945
Yuan X, Paez-Cortez J, Schmitt-Knosalla I, D’Addio F, Mfarrej B, Donnarumma M et al (2008) A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J Exp Med 205(13):3133–3144
Faust SM, Lu G, Marini BL, Zou W, Gordon D, Iwakura Y et al (2009) Role of T cell TGFβ signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection. J Immunol 183(11):7297–7306
Chadha R, Heidt S, Jones ND, Wood KJ (2011) Th17: contributors to allograft rejection and a barrier to the induction of transplantation tolerance? Transplantation 91(9):939–945. doi:10.1097/TP.0b013e3182126eeb
Long E, Wood KJ (2009) Regulatory T cells in transplantation: transferring mouse studies to the clinic. Transplantation 88(9):1050–1056
Wood KJ, Sakaguchi S (2003) Regulatory T cells in transplantation tolerance. Nat Rev Immunol 3:199–210
Wood KJ, Bushell A, Hester J (2012) Regulatory immune cells in transplantation. Nat Rev Immunol 12(6):417–430
Long E, Wood KJ (2007) Understanding FOXP3: progress towards achieving transplantation tolerance. Transplantation 84:459–461
Tarlinton DM, Batista F, Smith KGC (2008) The B-cell response to protein antigens in immunity and transplantation. Transplantation 85(12):1698–1704. doi:10.097/TP.0b013e3181777a39
Carroll MC (2004) The complement system in regulation of adaptive immunity. Nat Immunol 5(10):981–986
Cyster JG (2010) B cell follicles and antigen encounters of the third kind. Nat Immunol 11(11):989–996
Sarwal M, Chua M, Kambham N (2003) Molecular heterogeneity in acute renal allograft rejection identified by DNA Âmicroarray profiling. N Engl J Med 349:125
Naesens M, Zarkhin V, Kambham N, Li L, Kwok S, Hsieh S et al (2008) Evaluation of intra-graft B-cell subsets in renal allograft rejection: 664. Transplantation 86(2S):233–234. doi:10.1097/01.tp.0000332191.92932.c7
Zarkhin V, Li L, Sarwal M (2008) To B or not to B? B-cells and graft rejection. Transplantation 85(12):1705–1714. doi:10.097/TP.0b013e318177793e
Kwun J, Knechtle SJ (2009) Overcoming chronic rejection-can it B? Transplantation 88(8):955–961. doi:10.1097/TP.0b013e3181b96646
Thaunat O (2011) Pathophysiologic significance of B-cell clusters in chronically rejected grafts. Transplantation 92(2):121–126. doi:10.1097/TP.0b013e31821f74fe
Scheepstra C, Bemelman FJ, van der Loos C, Rowshani AT, van Donselaar-Van der Pant KA, Idu MM et al (2008) B cells in cluster or in a scattered pattern do not correlate with clinical outcome of renal allograft rejection. Transplantation 86(6):772–778. doi:10.1097/TP.0b013e3181860a74
Sagoo P, Perucha E, Sawitzki B, Tomiuk S, Stephens DA, Miqueu P et al (2010) Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest 120(6):1848–1861
Newell KA, Asare A, Kirk AD, Gisler TD, Bourcier K, Suthanthiran M et al (2010) Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 120(6):1836–1847
Le Texier L, Thebault P, Lavault A, Usal C, Merieau E, Quillard T et al (2011) Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile. Am J Transplant 11(3):429–438
Li XC (2010) The significance of non-T-cell pathways in graft rejection: implications for transplant tolerance. Transplantation 90(10):1043–1047. doi:10.97/TP.0b013e3181efcfe9
Kitchens WH et al (2007) Macrophage depletion suppresses cardiac allograft vasculopathy in mice. Am J Transplant 7:2675–2682
Summers C, Rankin SM, Condliffe AM, Singh N, Peters AM, Chilvers ER (2010) Neutrophil kinetics in health and disease. Trends Immunol 31(8):318–324
Asgari E, Zhou W, Sacks S (2010) Complement in organ transplantation. Curr Opin Organ Transplant 15(4):486–491. doi:10.1097/MOT.0b013e32833b9cb7
Lanier LL (2008) Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9(5):495–502
Kitchens WH, Uehara S, Chase CM, Colvin RB, Russell PS, Madsen JC (2006) The changing role of natural killer cells in solid organ rejection and tolerance. Transplantation 81(6):811–817. Âdoi:10.1097/01.tp.0000202844.33794.0e
Luster AD, Alon R, von Andrian UH (2005) Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol 6(12):1182–1190
Anglicheau D, Suthanthiran M (2008) Noninvasive prediction of organ graft rejection and outcome using gene expression patterns. Transplantation 86(2):192–199. doi:10.1097/TP.0b013e31817eef7b
Win TS, Pettigrew GJ (2010) Humoral autoimmunity and transplant vasculopathy: when allo is not enough. Transplantation 90(2):113–120. doi:10.1097/TP.0b013e3181e25a59
Terasaki PI, Cai J (2008) Human leukocyte antigen antibodies and chronic rejection: from association to causation. Transplantation 86(3):377–383. doi:10.1097/TP.0b013e31817c4cb8
Brook M, Wood K, Jones N (2006) The impact of memory T cells on rejection and tolerance. Transplantation 82:1–9
Adams A, Williams MA, Jones T, Shiasugi N, Durham MM, Kaech S et al (2003) Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 111:1887–1895
Acknowledgments
The work from the authors’ own laboratory described in this review was supported by grants from The Wellcome Trust, Medical Research Council, British Heart Foundation, Kidney Research UK, Garfield Weston Trust, and European Union through the Indices of Tolerance, RISET, OPTISTEM, TRIAD, and BioDRIM projects.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Wood, K.J., Zaitsu, M., Goto, R. (2013). Cell Mediated Rejection. In: Zachary, A., Leffell, M. (eds) Transplantation Immunology. Methods in Molecular Biology, vol 1034. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-493-7_3
Download citation
DOI: https://doi.org/10.1007/978-1-62703-493-7_3
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-492-0
Online ISBN: 978-1-62703-493-7
eBook Packages: Springer Protocols